DR. Alan Marvin Keller, M.D. is a hematology and oncology internal medicine in Tulsa, OK with 51 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Alan Marvin Keller, M.D. NPI is 1386696011. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE
Graduation Year:1973
The provider's business location address is:
12697 E 51ST ST
TULSA, OK
ZIP 74146-236
Phone: (918) 505-3200
Fax: (918) 505-3253
The NPI 1386696011 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
- Injection, fosaprepitant, 1 mg (HCPCS:J1453)
- Injection, denosumab, 1 mg (HCPCS:J0897)
- Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85025)
- Blood test, comprehensive group of blood chemicals (HCPCS:80053)
- Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
- Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour (HCPCS:96367)
- Infusion of chemotherapy into a vein up to 1 hour (HCPCS:96413)
- Injection beneath the skin or into muscle for therapy, diagnosis, or prevention (HCPCS:96372)
- Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour (HCPCS:96365)
- Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
- Nuclear medicine study with ct imaging skull base to mid-thigh (HCPCS:78815)
- Injection of different drug or substance into a vein for therapy, diagnosis, or prevention (HCPCS:96375)
- X-ray of chest, 2 views (HCPCS:71046)
- Ct scan chest (HCPCS:71250)
- Nuclear medicine study with ct imaging whole body (HCPCS:78816)
- Ct scan of abdomen and pelvis (HCPCS:74176)
- Ct scan guidance for insertion of radiation therapy fields (HCPCS:77014)
The enumeration date for this NPI number is 5/17/2006 and was last updated on 5/8/2014.